Diego Fonstad

Fondatore presso Bullet Biotechnology, Inc.

Health Technology

Consumer Services

Profilo

Diego Fonstad is the founder of Sutro Biopharma, Inc. (founded in 2004) and Bullet Biotechnology, Inc. (founded in 2011).
At Sutro Biopharma, he held the title of Vice President-Operations.
At Bullet Biotechnology, he held the title of Director.
Mr. Fonstad has an undergraduate degree from Harvard University and an MBA from Stanford University.

Posizioni attive di Diego Fonstad

Società	Posizione	Inizio
Bullet Biotechnology, Inc. Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA.	Fondatore	01/09/2011

Tutte le posizioni attive di Diego Fonstad

Precedenti posizioni note di Diego Fonstad

Società	Posizione	Fine
SUTRO BIOPHARMA, INC.	Fondatore	-

Vedi nel dettaglio l'esperienza di Diego Fonstad

Formazione di Diego Fonstad

Harvard University	Undergraduate Degree
Stanford University	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Diego Fonstad

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SUTRO BIOPHARMA, INC.	Health Technology

Aziende private	1
Bullet Biotechnology, Inc. Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA.	Health Technology